The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with the BD Horizon™ BV510 Mouse Anti-Human HLA-DR antibody (Cat. No. 563083; solid line histogram) or with a BD Horizon™ BV510 Mouse IgG2a, κ Isotype Control (Cat. No. 563027; dashed line histogram). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with the BD Horizon™ BV510 Mouse Anti-Human HLA-DR antibody (Cat. No. 563083; solid line histogram) or with a BD Horizon™ BV510 Mouse IgG2a, κ Isotype Control (Cat. No. 563027; dashed line histogram). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with the BD Horizon™ BV510 Mouse Anti-Human HLA-DR antibody (Cat. No. 563083; solid line histogram) or with a BD Horizon™ BV510 Mouse IgG2a, κ Isotype Control (Cat. No. 563027; dashed line histogram). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with the BD Horizon™ BV510 Mouse Anti-Human HLA-DR antibody (Cat. No. 563083; solid line histogram) or with a BD Horizon™ BV510 Mouse IgG2a, κ Isotype Control (Cat. No. 563027; dashed line histogram). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with the BD Horizon™ BV510 Mouse Anti-Human HLA-DR antibody (Cat. No. 563083; solid line histogram) or with a BD Horizon™ BV510 Mouse IgG2a, κ Isotype Control (Cat. No. 563027; dashed line histogram). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of HLA-DR expression on human peripheral blood lymphocytes and monocytes. Human whole blood was stained with the BD Horizon™ BV510 Mouse Anti-Human HLA-DR antibody (Cat. No. 563083; solid line histogram) or with a BD Horizon™ BV510 Mouse IgG2a, κ Isotype Control (Cat. No. 563027; dashed line histogram). The erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes (Left Panel) or monocytes (Right Panel). Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
The G46-6 monoclonal antibody specifically binds to HLA-DR, a major histocompatibility complex (MHC) class II antigen. HLA-DR antigens are encoded by genes within the Human Leukocyte Antigen (HLA) Complex located on chromosome 6. HLA-DR is a transmembrane heterodimeric glycoprotein composed of an α chain (36 kDa) and a β subunit (27 kDa) expressed primarily on antigen presenting cells: B cells, dendritic cells, monocytes, macrophages, and thymic epithelial cells. HLA-DR is also expressed on activated T cells. This molecule plays a major role in mediating cellular interactions during antigen presentation to CD4-positive T cells.
The antibody was conjugated to BD Horizon™ BV510 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max of 405-nm and Em Max at 510-nm, BD Horizon™ BV510 can be excited by the violet laser and detected in the BD Horizon™ V500 (525/50-nm) filter set. BD Horizon™ BV510 conjugates are useful for the detection of dim markers off the violet laser.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.